Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents

J Rheumatol. 2004 Aug;31(8):1607-13.

Abstract

Objective: Hip fracture is a common complication of osteoporosis, resulting in significant morbidity and mortality, with a high financial cost to the healthcare system. Hip protectors have been advocated as an effective method to prevent hip fractures in high-risk individuals. This study models the cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents.

Methods: An incremental cost-effectiveness analysis was performed comparing hip protectors to "no treatment" and to "calcium and vitamin D supplements." The study population was a hypothetical cohort of 1000 nursing home residents. A societal perspective, with a lifetime time horizon, was adopted. Data regarding costs, effectiveness, and quality of life measures were collected from the current literature and from Peace Arch Hospital, a community hospital in White Rock, British Columbia, Canada. Sensitivity analysis was performed.

Results: Hip protector use was found to be a dominant strategy compared to no treatment and to calcium and vitamin D supplements. Dominance implies lower cost and higher effect, generating cost-effectiveness ratios less than zero. Dominance with respect to cost and effectiveness of hip protectors in preventing hip fractures persisted when the model was subjected to probabilistic sensitivity analysis.

Conclusion: Cost-effectiveness analysis suggests that hip protectors could save money while preventing hip fractures and improving quality of life in nursing home residents.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Calcium / economics
  • Calcium / therapeutic use
  • Canada
  • Cost-Benefit Analysis
  • Drug Combinations
  • Drug Costs
  • Equipment Design
  • Female
  • Health Care Costs*
  • Hip Fractures / prevention & control*
  • Humans
  • Male
  • Nursing Homes / economics*
  • Osteoporosis / drug therapy
  • Protective Devices / economics*
  • Vitamin D / economics
  • Vitamin D / therapeutic use

Substances

  • Drug Combinations
  • Vitamin D
  • Calcium